SK146096A3 - Adenosine derivatives, processes for their preparation, their use for the preparation of drugs, their use in therapy and pharmaceutical compositions containing them - Google Patents

Adenosine derivatives, processes for their preparation, their use for the preparation of drugs, their use in therapy and pharmaceutical compositions containing them Download PDF

Info

Publication number
SK146096A3
SK146096A3 SK1460-96A SK146096A SK146096A3 SK 146096 A3 SK146096 A3 SK 146096A3 SK 146096 A SK146096 A SK 146096A SK 146096 A3 SK146096 A3 SK 146096A3
Authority
SK
Slovakia
Prior art keywords
compound
group
formula
carbon atoms
methyladenosine
Prior art date
Application number
SK1460-96A
Other languages
English (en)
Slovak (sk)
Inventor
Fulvio Gadient
Bonnie L K Mangold
John R Fozard
Mahavir Prashad
Prasad Koteswara Kapa
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9409324A external-priority patent/GB9409324D0/en
Priority claimed from GB9416693A external-priority patent/GB9416693D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of SK146096A3 publication Critical patent/SK146096A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SK1460-96A 1994-05-10 1995-05-09 Adenosine derivatives, processes for their preparation, their use for the preparation of drugs, their use in therapy and pharmaceutical compositions containing them SK146096A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9409324A GB9409324D0 (en) 1994-05-10 1994-05-10 New organic compounds, their preparation and use
US24991494A 1994-05-26 1994-05-26
GB9416693A GB9416693D0 (en) 1994-08-18 1994-08-18 Improvements in or relating to organic compounds
PCT/US1995/005802 WO1995030683A1 (en) 1994-05-10 1995-05-09 Adenosine derivatives

Publications (1)

Publication Number Publication Date
SK146096A3 true SK146096A3 (en) 1997-07-09

Family

ID=27267177

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1460-96A SK146096A3 (en) 1994-05-10 1995-05-09 Adenosine derivatives, processes for their preparation, their use for the preparation of drugs, their use in therapy and pharmaceutical compositions containing them

Country Status (13)

Country Link
EP (1) EP0759925A1 (no)
JP (1) JPH09512823A (no)
CN (1) CN1147815A (no)
AU (1) AU2546195A (no)
BR (1) BR9507683A (no)
CA (1) CA2186847A1 (no)
CZ (1) CZ327896A3 (no)
FI (1) FI964468A (no)
HU (1) HUT75338A (no)
NO (1) NO964735L (no)
PL (1) PL316985A1 (no)
SK (1) SK146096A3 (no)
WO (1) WO1995030683A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110902A (en) * 1997-06-23 2000-08-29 Moehler; Hanns Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine
GB0228723D0 (en) 2002-12-09 2003-01-15 Cambridge Biotechnology Ltd Treatment of pain
GB0305149D0 (en) * 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Compounds for the treatment of pain
EP2021350B1 (en) 2006-03-21 2016-12-21 Rheinische Friedrich-Wilhelms-Universität Bonn Phosphorylated a2a receptor agonists
CN108822174A (zh) * 2018-08-29 2018-11-16 上海兆维科技发展有限公司 新型核苷修饰物2’-eoe-鸟嘌呤核苷及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729994D0 (en) * 1987-12-23 1988-02-03 Glaxo Group Ltd Chemical compounds
GB2226027B (en) * 1988-12-13 1992-05-20 Sandoz Ltd Adenosine derivatives,their production and use
US5017578A (en) * 1989-06-09 1991-05-21 Hoechst-Roussel Pharmaceuticals Inc. N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents
HUT61567A (en) * 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
DK62692D0 (no) * 1992-05-14 1992-05-14 Novo Nordisk As

Also Published As

Publication number Publication date
EP0759925A1 (en) 1997-03-05
WO1995030683A1 (en) 1995-11-16
BR9507683A (pt) 1997-09-23
CN1147815A (zh) 1997-04-16
CZ327896A3 (en) 1997-03-12
FI964468A0 (fi) 1996-11-06
NO964735L (no) 1997-01-10
PL316985A1 (en) 1997-03-03
JPH09512823A (ja) 1997-12-22
FI964468A (fi) 1996-11-06
HUT75338A (en) 1997-05-28
HU9603105D0 (en) 1997-01-28
NO964735D0 (no) 1996-11-08
CA2186847A1 (en) 1995-11-16
AU2546195A (en) 1995-11-29

Similar Documents

Publication Publication Date Title
US5789416A (en) N6 mono heterocyclic substituted adenosine derivatives
US4985409A (en) Adenosine derivatives and pharmaceutical composition thereof
KR0137786B1 (ko) 심장 또는 뇌의 허혈성 질환의 치료, 예방제
EP0490818B1 (en) 6-cyclohexyl-2'-0-methyl-adenosine hydrate and uses thereof
MXPA04008008A (es) Agonistas parciales y completos de receptores de adenosina a1.
NO321216B1 (no) Blandinger for behandling av inflammatoriske reaksjoner
US20030176390A1 (en) Methods of treating insulin resistance syndrome and diabetes
SK146096A3 (en) Adenosine derivatives, processes for their preparation, their use for the preparation of drugs, their use in therapy and pharmaceutical compositions containing them
US3966916A (en) N(6)-disubstituted adenoisine compounds and therapeutic compositions
RU2340623C2 (ru) Частичные и полные агонисты аденозиновых рецепторов a1
US3880829A (en) N(6)-disubstituted adenosine compounds
US4016262A (en) Therapeutic compositions and methods employing N(6)-disubstituted adenosine compounds
JPS6197284A (ja) ピリジルフエニルピリダジノン変力剤
NZ505531A (en) 7-Propyl-8-oxo-alpha or beta-L-guanine alpha or beta-L-nucleoside
KR870001935B1 (ko) 항포진성을 갖는 뉴클레오시 유도체 및 그의 산부가염의 제조방법
MXPA96005046A (en) Derivatives of adenos
KR930003488B1 (ko) 신규 히단토인 유도체의 제조방법
CZ13192A3 (cs) Nové použití 2‘ -O-alkyladenosinových derivátů pro přípravu léčiva vhodného pro léčení neurodegenerativních poruch
PL166094B1 (pl) Sposób wytwarzania wodzianu 6-cykloheksylo-2’-0-metylo-adenozyny PL
HRP920648A2 (en) New crystalline form